Corteva (NYSE:CTVA) Releases FY 2025 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.700-2.950 for the period, compared to the consensus estimate of 3.190. The company issued revenue guidance of $17.2 billion-$17.6 billion, compared to the consensus revenue estimate of $17.3 billion.

Corteva Stock Performance

Shares of CTVA traded up $0.50 on Friday, reaching $62.86. The company’s stock had a trading volume of 1,187,593 shares, compared to its average volume of 3,619,594. The stock’s 50 day simple moving average is $60.22 and its two-hundred day simple moving average is $58.14. The stock has a market capitalization of $43.20 billion, a P/E ratio of 63.47, a PEG ratio of 1.71 and a beta of 0.78. Corteva has a 12-month low of $50.01 and a 12-month high of $66.24. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 0.96.

Corteva (NYSE:CTVA) last released its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 4.18% and a return on equity of 6.63%. Research analysts forecast that Corteva will post 2.58 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.08%. The ex-dividend date is Monday, March 3rd. Corteva’s dividend payout ratio is currently 68.69%.

Corteva declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, November 19th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the company to buy up to 7.5% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CTVA. Oppenheimer restated an “outperform” rating and set a $70.00 price objective (up previously from $69.00) on shares of Corteva in a research report on Friday, November 8th. KeyCorp increased their price target on Corteva from $68.00 to $70.00 and gave the stock an “overweight” rating in a research note on Friday. Bank of America increased their price target on shares of Corteva from $67.00 to $69.00 and gave the stock a “buy” rating in a research note on Wednesday, November 20th. Barclays lifted their price target on shares of Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 21st. Finally, Citigroup raised their target price on Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $67.19.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.